What Is COVID-19?
COVID-19 is caused by SARS-CoV-2, a highly transmissible respiratory coronavirus first identified in late 2019. Since then it has caused hundreds of millions of infections worldwide. In most healthy adults the illness is self-limiting and resembles a moderate upper respiratory infection, but certain populations — including adults over 65, immunocompromised individuals, those with diabetes, obesity, chronic lung or heart disease, and unvaccinated persons — face significantly higher risk of severe illness, hospitalization, and death. Current circulating variants continue to evolve, and updated booster vaccines remain one of the most effective tools for preventing serious outcomes.
SARS-CoV-2 enters host cells primarily by binding the angiotensin-converting enzyme 2 (ACE2) receptor via its spike protein. The virus then undergoes rapid replication in the upper and lower respiratory tract. In high-risk individuals this can trigger an exaggerated inflammatory response, leading to cytokine storm, acute respiratory distress syndrome (ARDS), multi-organ dysfunction, and, in some cases, long-term complications collectively referred to as Long COVID. According to the CDC and IDSA, early antiviral therapy is the most powerful intervention available to prevent progression to severe disease.
Telehealth is an ideal care setting for mild-to-moderate COVID-19 because it keeps infected patients safely at home rather than exposing others in a waiting room. At Innocre Telehealth, our board-certified provider, evaluates patients in Delaware, Maryland, and Washington for antiviral eligibility, reviews relevant medical history and current medications, and — when clinically appropriate — e-prescribes antivirals directly to your local pharmacy, all during the same-day visit.
Common Symptoms
Fever or chills
Temperature ≥100.4°F, often with rigors or sweating
Cough & sore throat
Dry or productive cough with pharyngeal irritation
Loss of taste or smell
Anosmia/ageusia — a hallmark finding of SARS-CoV-2 infection
Fatigue & body aches
Profound tiredness and diffuse myalgias
Headache
Often frontal or diffuse, can be severe
Shortness of breath
Mild dyspnea on exertion; severe SOB requires emergency care
Nasal congestion & runny nose
Common with Omicron-lineage variants
Gastrointestinal symptoms
Nausea, diarrhea, or vomiting in a subset of patients
How Innocre Treats COVID-19 Online
The cornerstone of early COVID-19 treatment for high-risk patients is oral antiviral therapy, which must be initiated within 5 days of symptom onset. Nirmatrelvir/ritonavir (Paxlovid) is the preferred agent per NIH and IDSA guidelines; it is a protease inhibitor combination that reduces the risk of hospitalization or death by approximately 89% in unvaccinated high-risk adults when started early. During your visit, your board-certified provider reviews your complete medication list — Paxlovid carries significant drug–drug interactions with medications such as statins, certain antiarrhythmics, and immunosuppressants — and adjusts the treatment plan accordingly. Molnupiravir (Lagevrio), a nucleoside analogue that impairs viral RNA replication, is an alternative for patients for whom Paxlovid is contraindicated; it carries a modest 30% risk reduction and is not recommended in pregnancy.
A positive COVID-19 test result — whether a home rapid antigen test or a PCR — is required before an antiviral prescription can be issued. your provider will review your test result during the visit, assess your risk factors and current health status, and determine eligibility under current IDSA and HHS guidelines. Supportive care guidance is also provided: symptom management with acetaminophen or ibuprofen, adequate hydration, rest, and pulse oximetry monitoring at home for patients with oximeters. Patients in Delaware, Maryland, and Washington can receive e-prescriptions sent directly to their preferred pharmacy.
Paxlovid rebound — a return of COVID-19 symptoms or a new positive test approximately 2–8 days after completing the 5-day course — occurs in a minority of patients and is typically mild. your provider discusses rebound risk management during your visit and provides guidance on monitoring. Patients with Long COVID symptoms (brain fog, persistent fatigue, post-exertional malaise lasting more than 12 weeks) are referred to appropriate specialist care and supported with a structured follow-up plan.
⚠️ When to Go to the Emergency Room
Telehealth is appropriate for mild-to-moderate COVID-19. Seek emergency care immediately if you experience:
- • Severe difficulty breathing, gasping for air, or inability to complete a full sentence
- • Persistent chest pain or pressure that does not resolve with rest
- • New confusion, disorientation, altered mental status, or inability to stay awake
- • Bluish or grayish discoloration of the lips, fingernails, or skin (cyanosis)
- • Oxygen saturation below 94% on a home pulse oximeter, or any reading below 90%